葵花药业(002737.SZ)：复方聚乙二醇(3350)电解质口服溶液获药品注册证

Core Viewpoint - The company has received a drug registration certificate from the National Medical Products Administration for its product, a compound polyethylene glycol (3350) electrolyte oral solution, which is approved for the treatment of chronic constipation and fecal impaction [1] Group 1 - The product is specifically indicated for treating chronic constipation and fecal impaction [1]